General & Plastic Surgery Devices - Ghana

The General & Plastic Surgery Devices market market in Ghana is set to witness a significant growth in revenue, with projections indicating that it will reach a staggering US$7.23m by the year 2024.
This growth is expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 6.83%.
As a result, the market volume is projected to reach an impressive US$10.06m by 2029.
When comparing the global market, it is worth noting that the United States is anticipated to generate the highest revenue, with an estimated value of US$9.84bn in 2024.
Ghana's demand for General & Plastic Surgery Devices in the Medical Technology market is steadily growing due to an increase in disposable income and a growing awareness of cosmetic procedures.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Ghana has been experiencing steady growth in recent years, driven by a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Ghana have been shifting towards a greater focus on personal appearance and self-care. As the country's middle class continues to expand, more individuals are able to afford cosmetic procedures and are willing to invest in their physical appearance. This has led to an increased demand for general and plastic surgery devices, as both healthcare professionals and patients seek the latest technologies and innovations in the field. Trends in the market have also played a significant role in the growth of the General & Plastic Surgery Devices market in Ghana. Technological advancements have made procedures safer, more effective, and less invasive, leading to increased patient satisfaction and confidence in the outcomes. Additionally, the rise of medical tourism in the region has attracted patients from neighboring countries who are seeking high-quality healthcare services at a lower cost. Local special circumstances in Ghana have contributed to the growth of the General & Plastic Surgery Devices market as well. The country's healthcare infrastructure has been improving, with more hospitals and clinics offering specialized services in cosmetic and reconstructive surgery. This has created a favorable environment for the adoption of advanced medical devices and technologies. Underlying macroeconomic factors have also played a role in the development of the General & Plastic Surgery Devices market in Ghana. The country's strong economic growth and rising disposable incomes have increased the affordability of cosmetic procedures for a larger segment of the population. Furthermore, the government's commitment to healthcare development and investment in medical infrastructure has provided a supportive environment for the growth of the market. In conclusion, the General & Plastic Surgery Devices market in Ghana is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As the country continues to develop and the demand for cosmetic procedures increases, the market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.